Antisense oligonucleotides targeting c-fos mRNA inhibit rheumatoid synovial fibroblast proliferation.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 9613344.
- Also identified by PMC identifier 1752536.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine whether antisense oligonucleotides targeting c-fos mRNA have the ability to inhibit the growth of interleukin 1 (IL1) stimulated fibroblast-like cells from the synovium in rheumatoid arthritis (RA). Fibroblast-like cells established from RA synovium were stimulated by IL1 with antisense or sense oligonucleotides complementary to c-fos mRNA, and the proliferation of these cells was determined by 3H-thymidine incorporation. Effect of antisense oligonucleotides on expression of activator protein 1 (AP1) activity was evaluated using electrophoretic mobility shift assay. C-fos antisense oligonucleotides inhibited IL1 stimulated synovial fibroblast proliferation. The expression of AP1 activity induced by IL1 was suppressed by treatment with antisense oligonucleotides. These results suggest the feasibility of antisense strategies designed to suppress c-fos expression as therapeutic agents for RA.
Medical subject headings
- Arthritis, Rheumatoid
- Fibroblasts
- Gene Targeting
- Homeodomain Proteins
- Oligonucleotides, Antisense
- Proto-Oncogene Proteins c-bcl-2
- Proto-Oncogene Proteins c-fos
- Repressor Proteins
- Saccharomyces cerevisiae Proteins
- Synovial Membrane